Atabak Mokari
Chief Financial Officer · CORCEPT THERAPEUTICS INC
- 2024
- Sep 4, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Atabak Mokari files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sean Maduck - $24.47M in CORT purchases and sales in the last 12 months
- David L. Mahoney - $13.94M in CORT purchases and sales in the last 12 months
- William Guyer - $13.48M in CORT purchases and sales in the last 12 months
- Joseph K. Belanoff - $10.38M in CORT purchases and sales in the last 12 months
- Roberto Wandenkolk Vieira - $7.46M in CORT purchases and sales in the last 12 months
- James N. Wilson - $3.94M in CORT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Atabak Mokari?
Atabak Mokari is a corporate insider, tracked as Chief Financial Officer of CORCEPT THERAPEUTICS INC (CORT). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Atabak Mokari submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Atabak Mokari been buying or selling stock?
Recorded transactions: 0 open-market purchases and 22 open-market sales ($18.73M) across all tracked filings.
